The Dipeptidyl Peptidase-4 Inhibitor Linagliptin Preserves Endothelial Function in Mesenteric Arteries from Type 1 Diabetic Rats without Decreasing Plasma Glucose

Open Access

Peer-reviewed

Research Article

Salheen M. Salheen,

Affiliation School of Medical Sciences, RMIT University, Bundoora, Victoria, Australia
⨯
Usha Panchapakesan,

Affiliation Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St Leonards, New South Wales, Australia
⨯
Carol A. Pollock,

Affiliation Kolling Institute of Medical Research, Royal North Shore Hospital, University of Sydney, St Leonards, New South Wales, Australia
⨯
Owen L. Woodman

* E-mail: owen.woodman@rmit.edu.au

Affiliation School of Medical Sciences, RMIT University, Bundoora, Victoria, Australia
⨯

Reader Comments (0)

Diabetes mellitus
Is the Subject Area "Diabetes mellitus" applicable to this article?

Thanks for your feedback.
Mesenteric arteries
Is the Subject Area "Mesenteric arteries" applicable to this article?

Thanks for your feedback.
Superoxides
Is the Subject Area "Superoxides" applicable to this article?

Thanks for your feedback.
Glucose
Is the Subject Area "Glucose" applicable to this article?

Thanks for your feedback.
Nitric oxide
Is the Subject Area "Nitric oxide" applicable to this article?

Thanks for your feedback.
Blood sugar
Is the Subject Area "Blood sugar" applicable to this article?

Thanks for your feedback.
Oxidative stress
Is the Subject Area "Oxidative stress" applicable to this article?

Thanks for your feedback.
Type 1 diabetes
Is the Subject Area "Type 1 diabetes" applicable to this article?

Thanks for your feedback.